| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.43 | 0.01 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |